Is RNXT or ICU more profitable?

RenovoRx has a net margin of -621.71% compared to SeaStar Medical's net margin of -795.51%. RenovoRx's return on equity of -135.11% beat SeaStar Medical's return on equity. Company Net Margins Return on Equity Return on Assets RenovoRx -621.71% -135.11% -101.91% SeaStar Medical -795.51% -162.75% -109.89%

Does the media favor RNXT or ICU?

In the previous week, RenovoRx had 7 more articles in the media than SeaStar Medical. MarketBeat recorded 13 mentions for RenovoRx and 6 mentions for SeaStar Medical. RenovoRx's average media sentiment score of 0.18 beat SeaStar Medical's score of -0.20 indicating that RenovoRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RenovoRx 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SeaStar Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ICU or MDAI?

In the previous week, SeaStar Medical and SeaStar Medical both had 6 articles in the media. Spectral AI's average media sentiment score of 0.07 beat SeaStar Medical's score of -0.20 indicating that Spectral AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SeaStar Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Spectral AI 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer HSAQ or ICU?

SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 146.15%. Given SeaStar Medical's stronger consensus rating and higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Health Sciences Acquisitions Co. 2. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, HSAQ or ICU?

Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than SeaStar Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Health Sciences Acquisitions Co. 2 N/A N/A -$380K N/A N/A SeaStar Medical $1.23M 11.65 -$12.15M -$3.91 N/A

Do analysts recommend POCI or ICU?

SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 146.15%. Given SeaStar Medical's stronger consensus rating and higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer POCI or ICU?

In the previous week, SeaStar Medical had 3 more articles in the media than Precision Optics. MarketBeat recorded 6 mentions for SeaStar Medical and 3 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.00 beat SeaStar Medical's score of -0.20 indicating that Precision Optics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precision Optics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SeaStar Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ICU or SRTS?

In the previous week, SeaStar Medical had 4 more articles in the media than Sensus Healthcare. MarketBeat recorded 6 mentions for SeaStar Medical and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.51 beat SeaStar Medical's score of -0.20 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SeaStar Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Sensus Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

SeaStar Medical (ICU) Competitors

$3.25 -0.10 (-2.99%)

As of 12:23 PM Eastern

Compare

ICU vs. RNXT, MDAI, HSAQ, POCI, and SRTS

Should you buy SeaStar Medical stock or one of its competitors? SeaStar Medical's main competitors and comparable companies include RenovoRx (RNXT), Spectral AI (MDAI), Health Sciences Acquisitions Co. 2 (HSAQ), Precision Optics (POCI), and Sensus Healthcare (SRTS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SeaStar Medical compare to RenovoRx?

RenovoRx (NASDAQ:RNXT) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

RenovoRx has higher earnings, but lower revenue than SeaStar Medical. RenovoRx is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RenovoRx	$1.12M	52.34	-$11.17M	-$0.31	N/A
SeaStar Medical	$1.23M	11.65	-$12.15M	-$3.91	N/A

RenovoRx has a net margin of -621.71% compared to SeaStar Medical's net margin of -795.51%. RenovoRx's return on equity of -135.11% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RenovoRx	-621.71%	-135.11%	-101.91%
SeaStar Medical	-795.51%	-162.75%	-109.89%

RenovoRx has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market.

3.1% of RenovoRx shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 9.4% of RenovoRx shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, RenovoRx had 7 more articles in the media than SeaStar Medical. MarketBeat recorded 13 mentions for RenovoRx and 6 mentions for SeaStar Medical. RenovoRx's average media sentiment score of 0.18 beat SeaStar Medical's score of -0.20 indicating that RenovoRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RenovoRx	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SeaStar Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

RenovoRx presently has a consensus price target of $8.50, suggesting a potential upside of 554.35%. SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 146.15%. Given RenovoRx's stronger consensus rating and higher possible upside, equities research analysts clearly believe RenovoRx is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RenovoRx	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

RenovoRx beats SeaStar Medical on 15 of the 17 factors compared between the two stocks.

How does SeaStar Medical compare to Spectral AI?

SeaStar Medical (NASDAQ:ICU) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Spectral AI has a net margin of -69.27% compared to SeaStar Medical's net margin of -795.51%. Spectral AI's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-795.51%	-162.75%	-109.89%
Spectral AI	-69.27%	N/A	-78.56%

In the previous week, SeaStar Medical and SeaStar Medical both had 6 articles in the media. Spectral AI's average media sentiment score of 0.07 beat SeaStar Medical's score of -0.20 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Spectral AI	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

SeaStar Medical currently has a consensus price target of $8.00, suggesting a potential upside of 146.15%. Spectral AI has a consensus price target of $4.00, suggesting a potential upside of 147.52%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts clearly believe Spectral AI is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Spectral AI has higher revenue and earnings than SeaStar Medical. Spectral AI is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	11.65	-$12.15M	-$3.91	N/A
Spectral AI	$15.39M	3.34	-$7.57M	-$0.35	N/A

SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

Summary

Spectral AI beats SeaStar Medical on 13 of the 15 factors compared between the two stocks.

How does SeaStar Medical compare to Health Sciences Acquisitions Co. 2?

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations and profitability.

SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 146.15%. Given SeaStar Medical's stronger consensus rating and higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Health Sciences Acquisitions Co. 2.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Sciences Acquisitions Co. 2	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, meaning that its share price is 205% less volatile than the broader market.

Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than SeaStar Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380K	N/A	N/A
SeaStar Medical	$1.23M	11.65	-$12.15M	-$3.91	N/A

Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to SeaStar Medical's net margin of -795.51%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%
SeaStar Medical	-795.51%	-162.75%	-109.89%

In the previous week, SeaStar Medical had 6 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 6 mentions for SeaStar Medical and 0 mentions for Health Sciences Acquisitions Co. 2. Health Sciences Acquisitions Co. 2's average media sentiment score of 0.00 beat SeaStar Medical's score of -0.20 indicating that Health Sciences Acquisitions Co. 2 is being referred to more favorably in the media.

Company	Overall Sentiment
Health Sciences Acquisitions Co. 2	Neutral
SeaStar Medical	Neutral

89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Health Sciences Acquisitions Co. 2 beats SeaStar Medical on 8 of the 13 factors compared between the two stocks.

How does SeaStar Medical compare to Precision Optics?

Precision Optics (NASDAQ:POCI) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

Precision Optics has higher revenue and earnings than SeaStar Medical. Precision Optics is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$19.09M	2.53	-$5.78M	-$0.63	N/A
SeaStar Medical	$1.23M	11.65	-$12.15M	-$3.91	N/A

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 14.4% of Precision Optics shares are owned by insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Precision Optics has a beta of 0.34, indicating that its stock price is 66% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market.

In the previous week, SeaStar Medical had 3 more articles in the media than Precision Optics. MarketBeat recorded 6 mentions for SeaStar Medical and 3 mentions for Precision Optics. Precision Optics' average media sentiment score of 0.00 beat SeaStar Medical's score of -0.20 indicating that Precision Optics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Precision Optics	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SeaStar Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Precision Optics has a net margin of -17.03% compared to SeaStar Medical's net margin of -795.51%. Precision Optics' return on equity of -37.47% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precision Optics	-17.03%	-37.47%	-19.96%
SeaStar Medical	-795.51%	-162.75%	-109.89%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Precision Optics beats SeaStar Medical on 10 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Sensus Healthcare?

SeaStar Medical (NASDAQ:ICU) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Sensus Healthcare has a net margin of -88.45% compared to SeaStar Medical's net margin of -795.51%. Sensus Healthcare's return on equity of -21.57% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-795.51%	-162.75%	-109.89%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Sensus Healthcare has higher revenue and earnings than SeaStar Medical. Sensus Healthcare is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	11.65	-$12.15M	-$3.91	N/A
Sensus Healthcare	$17.51M	3.03	-$7.72M	-$0.94	N/A

SeaStar Medical has a beta of -1.05, suggesting that its share price is 205% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market.

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

SeaStar Medical currently has a consensus target price of $8.00, indicating a potential upside of 146.15%. Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 80.88%. Given SeaStar Medical's higher probable upside, research analysts clearly believe SeaStar Medical is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, SeaStar Medical had 4 more articles in the media than Sensus Healthcare. MarketBeat recorded 6 mentions for SeaStar Medical and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.51 beat SeaStar Medical's score of -0.20 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sensus Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sensus Healthcare beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICU vs. The Competition

Export

Metric	SeaStar Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$14.33M	$5.84B	$7.28B	$12.76B
Dividend Yield	N/A	1.75%	2.54%	10.79%
P/E Ratio	-0.83	26.24	271.38	24.12
Price / Sales	11.65	70.17	612.61	78.45
Price / Cash	N/A	33.71	29.03	36.90
Price / Book	1.18	6.22	11.17	6.40
Net Income	-$12.15M	$149.30M	$3.46B	$348.28M
7 Day Performance	N/A	1.03%	2.07%	1.29%
1 Month Performance	-13.33%	9.02%	7.44%	5.47%
1 Year Performance	-59.38%	7.42%	24.72%	16.27%

SeaStar Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICU SeaStar Medical	3.3356 of 5 stars	$3.25 -3.0%	$8.00 +146.2%	-58.1%	$14.33M	$1.23M	N/A	2	Analyst Downgrade
RNXT RenovoRx	3.5146 of 5 stars	$1.17 -2.5%	$8.50 +626.5%	+40.4%	$54.06M	$1.98M	N/A	6
MDAI Spectral AI	2.9974 of 5 stars	$1.61 -1.8%	$4.00 +148.4%	-23.4%	$53.46M	$19.65M	N/A	83	Analyst Downgrade
HSAQ Health Sciences Acquisitions Co. 2	N/A	$4.72 +7.0%	N/A	+110.2%	$52.92M	N/A	N/A	4
POCI Precision Optics	0.1337 of 5 stars	$4.34 +3.8%	N/A	-5.0%	$47.99M	$19.09M	N/A	80	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ICU) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SeaStar Medical (ICU) Competitors

ICU vs. RNXT, MDAI, HSAQ, POCI, and SRTS

How does SeaStar Medical compare to RenovoRx?

Summary

How does SeaStar Medical compare to Spectral AI?

Summary

How does SeaStar Medical compare to Health Sciences Acquisitions Co. 2?

Summary

How does SeaStar Medical compare to Precision Optics?

Summary

How does SeaStar Medical compare to Sensus Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICU vs. The Competition

SeaStar Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SeaStar Medical (ICU) Competitors

ICU vs. RNXT, MDAI, HSAQ, POCI, and SRTS

How does SeaStar Medical compare to RenovoRx?

Which has better valuation & earnings, RNXT or ICU?

Is RNXT or ICU more profitable?

Which has more volatility and risk, RNXT or ICU?

Do insiders and institutionals hold more shares of RNXT or ICU?

Does the media favor RNXT or ICU?

Do analysts prefer RNXT or ICU?

Summary

How does SeaStar Medical compare to Spectral AI?

Is ICU or MDAI more profitable?

Does the media prefer ICU or MDAI?

Do analysts rate ICU or MDAI?

Do institutionals and insiders hold more shares of ICU or MDAI?

Which has stronger earnings and valuation, ICU or MDAI?

Which has more risk & volatility, ICU or MDAI?

Summary

How does SeaStar Medical compare to Health Sciences Acquisitions Co. 2?

Do analysts prefer HSAQ or ICU?

Which has more risk & volatility, HSAQ or ICU?

Which has preferable valuation and earnings, HSAQ or ICU?

Is HSAQ or ICU more profitable?

Does the media favor HSAQ or ICU?

Do insiders & institutionals believe in HSAQ or ICU?

Summary

How does SeaStar Medical compare to Precision Optics?

Which has preferable valuation & earnings, POCI or ICU?

Do insiders and institutionals hold more shares of POCI or ICU?

Which has more risk & volatility, POCI or ICU?

Does the media prefer POCI or ICU?

Is POCI or ICU more profitable?

Do analysts recommend POCI or ICU?

Summary

How does SeaStar Medical compare to Sensus Healthcare?

Is ICU or SRTS more profitable?

Which has stronger valuation and earnings, ICU or SRTS?

Which has more risk & volatility, ICU or SRTS?

Do insiders & institutionals believe in ICU or SRTS?

Do analysts rate ICU or SRTS?

Does the media prefer ICU or SRTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICU vs. The Competition

SeaStar Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools